Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 340 participants.

Also called NCT05825573

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 340 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05825573
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France, Réunion (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05825573. Randomized; no masking; primary purpose treatment. Start 2023-05-15 (actual); primary completion 2025-02-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus
Acronym
ARGONAUT
Condition
Intracardiac Thrombus
Condition
STEMI
Condition
Heart Failure
Intervention (Drug)
Vitamin K antagonist
Intervention (Drug)
Direct oral anticoagulant
Lead sponsor
Centre Hospitalier Universitaire de Nīmes (class: other)

Record details

Record id
cardio:ct-nct05825573
Content hash
6a769f042b76088f287690e66c8a65286c6dc1cc54f0a3fa171371b9a4d9c77c